| Change in Average E/e’ | Change in LAVi, ml/m2 | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
 | Univariate |  | Multivariable |  | Univariate |  | Multivariable |  |  | |
 | Beta (95%CI) | p-value | Beta (95%CI) | p-value | Beta (95%CI) | p-value | Beta (95%CI) | p-value |  | |
TSP2, ng/ml | 0.90 (0.15–1.66) | 0.02 | 0.75 (0.02–1.49) | 0.04 | 3.41 (0.54–6.28) | 0.02 | 4.12 (1.48–6.77) | < 0.01 |  | |
Baseline Average E/e’ | −0.16 (−0.29–−0.03) | 0.02 | −0.24 (−0.38–−0.09) | < 0.01 |  |  |  |  |  | |
Baseline LAVi, ml/m2 |  |  |  |  | −0.37 (−0.51–−0.23) | < 0.001 | −0.42 (−0.56–−0.28) | < 0.001 |  | |
Age, years | 0.00 (−0.04–0.04) | 0.96 | 0.02 (−0.03–0.06) | 0.46 | 0.12 (−0.02–0.26) | 0.09 | 0.09 (−0.05–0.22) | 0.23 |  | |
Men | 0.12 (−0.62–0.85) | 0.76 | −0.03 (−0.72–0.66) | 0.93 | −0.82 (−3.53–1.89) | 0.55 | −0.53 (−2.94–1.87) | 0.66 |  | |
Duration of DM, years* | −0.80 (−2.66–1.07) | 0.40 |  |  | 0.17 (−6.40–6.73) | 0.96 |  |  |  | |
BMI, kg/m2 | 0.07 (−0.01–0.15) | 0.09 | 0.05 (−0.03–0.12) | 0.20 | 0.00 (−0.30–0.30) | 0.98 | −0.03 (−0.30–0.24) | 0.84 |  | |
Systolic BP, mmHg | 0.02 (−0.01–0.04) | 0.15 |  |  | 0.07 (−0.01–0.14) | 0.08 | 0.07 (0.00–0.14) | 0.05 |  | |
Diastolic BP, mmHg | 0.03 (−0.01–0.08) | 0.12 |  |  | −0.01 (−0.17–0.16) | 0.94 |  |  |  | |
Smoker | 0.12 (−0.72–0.97) | 0.77 |  |  | 1.26 (−1.78–4.29) | 0.42 |  |  |  | |
Hypertension | 1.06 (0.19–1.92) | 0.02 | 1.03 (0.16–1.90) | 0.02 | −0.10 (−3.37–3.18) | 0.95 |  |  |  | |
Dyslipidemia | 1.02 (0.21–1.84) | 0.01 | 0.86 (0.10–1.63) | 0.03 | 1.98 (−1.13–5.09) | 0.21 |  |  |  | |
CKD stage ≥ 3 | 0.31 (−0.76–1.38) | 0.57 |  |  | 3.70 (−0.03–7.43) | 0.05 | 0.71 (−2.86–4.28) | 0.70 |  | |
HbA1c, % | 0.17 (−0.12–0.46) | 0.26 |  |  | 1.23 (0.20–2.26) | 0.02 | −0.13 (−1.10–1.36) | 0.83 |  | |
HbA1c, mmol/mol | 0.02 (−0.01–0.04) | 0.26 |  |  | 0.11 (0.02–0.21) | 0.02 | 0.01 (−0.10–0.12) | 0.83 |  | |
FG, mg/dL | 0.00 (−0.01–0.01) | 0.94 |  |  | 0.03 (0.00–0.06) | 0.04 | 0.06 (−0.52–0.64) | 0.84 |  | |
eGFR*, ml/min/1.73m2 | −0.96 (−3.75–1.83) | 0.50 |  |  | −12.99 (−22.87–−3.10) | 0.01 |  |  |  | |
HDL-C, mg/dL | −0.03 (−0.06–0.00) | 0.04 |  |  | 0.02 (−0.09–0.12) | 0.75 |  |  |  | |
LDL-C, mg/dL | −0.02 (−0.04–−0.01) | < 0.01 |  |  | −0.02 (−0.07–0.04) | 0.57 |  |  |  | |
Triglyceride*, mg/dL | 0.00 (0.00–0.00) | 0.53 |  |  | 0.00 (−0.01–0.01) | 0.92 |  |  |  | |
Insulin | 0.72 (−0.01–1.45) | 0.05 | 0.37 (−0.32–1.05) | 0.30 | 1.47 (−1.24–4.19) | 0.29 |  |  |  | |
Metformin | 1.06 (−0.91–3.02) | 0.29 |  |  | −1.48 (−8.58–5.62) | 0.68 |  |  |  | |
Sulfonylureas | −0.10 (−0.83–0.64) | 0.80 |  |  | −1.19 (−3.89–1.51) | 0.39 |  |  |  | |
DPP4i | 0.01 (−0.90–0.91) | 0.98 |  |  | −0.33 (−3.69–3.03) | 0.85 |  |  |  | |
ACEI/ARB | 0.47 (−0.30–1.22) | 0.23 |  |  | −0.01 (−2.80–2.78) | 0.99 |  |  |  | |
Beta blocker | 0.55 (−0.22–1.32) | 0.16 |  |  | 1.35 (−1.48–4.19) | 0.35 |  |  |  | |
CCB | 0.78 (0.05–1.50) | 0.04 |  |  | 2.39 (−0.28–5.06) | 0.08 |  |  |  | |
Diuretics | 0.88 (−0.37–2.14) | 0.17 |  |  | 1.36 (−3.18–5.91) | 0.56 |  |  |  | |
Statin | 0.95 (0.22–1.68) | 0.01 |  |  | −0.31 (−3.06–2.46) | 0.83 |  |  |  |